Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$EDXC - Endexx Corporation is poised for massive success in the plant-based wellness and vape market. With expansions across the Middle East and Europe, their HYLA division is capturing diverse consumer bases. Plus, upcoming name and symbol change signals a potential surge in stock performance. Get in now before the market catches on!
https://marketsherald.com/vaping-the-future-why-endexxs-hyla-maybe-the-next-big-wave-in-your-investment-portfolio/
Little more to go on msos i have a feeling but mj getting close
Banking coming back around..."Democrats Plan to Take Another Pass at Cannabis Banking Bill":
MARCH 7, 2023
"A Republican Senate aide confirmed that Sen. Cynthia Lummis, a Wyoming Republican, is co-sponsoring a marijuana banking bill with Democratic Banking Chairman Sherrod Brown of Ohio. A cannabis industry source said the bill could be made public later this month."
https://www.route-fifty.com/public-safety/2023/03/democrats-plan-take-another-pass-cannabis-banking-bill/383711/
$CWBHF-"Elon Musk Takes Twitter To Another Level: Greenlights Paid Ads For Cannabis & THC Products In US":
February 15, 2023
https://www.benzinga.com/markets/cannabis/23/02/30922774/elon-musk-takes-twitter-to-another-level-greenlights-paid-ads-for-cannabis-thc-products-in-us
"Twitter’s New Marijuana Advertising Policy Still Doesn’t Allow Ads For Marijuana Product Sales":
February 15, 2023
"“Advertisers may not promote or offer the sale of Cannabis (including CBD– cannabinoids),” it says. The exception is ads for “topical (non-ingestible) hemp-derived CBD topical products containing equal to or less than the 0.3 percent THC government-set threshold.”
Sector seems to be bottoming here. Legalization coming soon I'd say. Bad news baked in.
$PVSP The current team has cleaned up the business.
San Francisco Examiner Picks Livewire's Estrella River Farms as one of the 12 Best Flower Brands for 2023 in the Bay Area
12 Best Flower Brands for 2023 In San Francisco Bay Area
According to a Pew Research study, 59% of Americans believe recreational cannabis consumption should be legal for adults. The “Stoner Stigma” is falling away and cannabis consumption can be compared to drinking wine; a social ritual that relaxes you and elevates the experience. Just like fine wine grape vines, premium cannabis is carefully cultivated. Tended with care and science - the ultimate focus is on the final product for the consumer. The CDFA’s Cannabis Appellations Program (CAP) is working toward making cannabis cultivation regional designations on par with those of Napa and Sonoma Valley. There is even a sommelier of cannabis certification - a ganjier - program available in Humboldt County. Flower and genetic brands are like the vintners (herbners?) of cannabis. Some grow and package the best, others find and combine the best. Here are the best “herbners” to watch in 2023.
The Livewire Estate Grown Weedery
Estrella Ranch is a historic ranch property in Paso Robles, the center of California wine country. Through its subsidiary Estrella Ranch Partners, the Company has transformed this stunning property into the world's first "Estate Grown Weedery," with three acres of high-end, organic sun-grown cannabis products and eventually becoming the ultimate Cannabis tourist and education destination. Estrella Ranch is the central hub for all Livewire operations in California and shares valuable resources as needed with Livewire’s subsidiary Makana Ola Ranch in Humboldt, California. Makana Ola Farms is a 40-acre property with a 10,000 sqft cultivation area located in the heart of Humboldt County in Northern California, the birthplace of California's cannabis cultivation. Makana Ola is a well-guarded secret of unique marijuana horticulture with a long tradition of quietly growing amongst the giant redwoods. The Livewire Estate Grown Weedery cultivation approach focuses on the cost-effective production of the best quality organic-style cannabis in California while generating the smallest possible carbon footprint and using as few of California's energy resources as possible. Visit https://estrellariverfarms.com.
About?LiveWire?Ergogenics?Inc.
The Company focuses on acquiring, managing, and licensing well-qualified cannabis real estate locations of fully compliant facilities to produce cannabis-based products for statewide distribution in California. This includes developing and licensing high-quality organic cannabinoid-based specialty products and services to create the high-quality "Estrella Estate Grown Weedery™" brand, cultivated by its subsidiary/affiliate companies Estrella Ranch Partners, Estrella River Farms, and Makana Ola. LiveWire Ergogenics does not produce, sell, or distribute products that violate the United States Controlled Substances Act. For more information about LiveWire Ergogenics, visit?www.livewireergogenics.com. For non-material updates, follow LiveWire Ergogenics on Twitter @livewireLVVV, or go to?www.stockwatchindex.com/livewire-ergogenics.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or the Company's future performance. Readers are cautioned not to rely on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should carefully review various risks and uncertainties identified in this release, the Company's Social Media postings, and matters set in the Company's SEC filings. These risks and uncertainties could cause the Company's actual results to differ materially from those indicated in the forward-looking statements.
LIVEWIRE ERGOGENICS, INC 1600 North Kraemer Blvd. Anaheim, CA 92806
714-740-5144 www.livewireergogenics.com info@livewireergogenics.com
MARKET AWARENESS Stockwatchindex, LLC
442-287-8059 www.stockwatchindex.com info@stockwatchindex.com
LIVEWIRE INVESTOR RELATIONS Tristan Cavato
805-835-2415 ir@livewireergogenics.com info@livewireergogenics.com
Stay Tuned - The Story Continues
$PVSP The Company’s ongoing audit work has also produced several tax adjustments from prior years, dating back to 2017. Due to the net operating loss carryforward, Pervasip did not recognize income tax expense in the nine-month periods ended August 31, 2022, and 2021. However, the VIEs that are included in the consolidated financial statements, have recorded a tax expense and a current income tax liability. Recent court cases regarding the interpretation of IRC 280E have made it more likely than not that the net operating loss deduction in the VIEs would be disallowed. Consequently, the company recorded tax provisions for its VIEs. Rather than re-stating prior years the Company decided to account for all adjustments in this quarter. Of the $1,503,376 booked in the Income Statement, $686,688 is tax and penalties from previous years and the rest estimated taxes for 2022 year to date.
In addition, $589,485 in Other Expenses in the Income Statement, includes a $342,000 tax adjustment from 2017 legacy payroll tax and a $163,718 charge from Pervasip which is from loss on debt conversion with Mammoth and derivatives.
Accrued expenses of $1,066,575 includes $254,549 in utility rebate contingency. That contingency will be lifted in Q4 as final commissioning by the utility was completed after the third quarter close and a full rebate of $288,000 was approved.
https://marketwirenews.com/news-releases/pervasip-announces-3rd-quarter-financials-7395374803366177.html
$EDXC - Endexx Corporation having grown in over 6,500 FDM stores nationwide, is now announcing entry into thousands of Target stores making it possibly one of the largest hemp-based product retailers worldwide. $EDXC got a spike today, get in!
https://www.globenewswire.com/news-release/2022/07/19/2481808/0/en/Endexx-s-New-Blesswell-Skincare-Line-Introduced-in-Select-Target-Stores-Nationwide.html
$PVSP Twitter status update: https://twitter.com/PervasipC
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
$PVSP ZAM provides consulting, leasing, intellectual property licensing and other long-term arrangements to cannabis operators, including management of the Artizen™ brand assets
https://www.pervasip.net/zen-asset-management-zam
Endexx Talks Potential OTCQB Up-List, 2021 And Fourth Quarter Financials, Growth Plans
Endexx Corporation CEO Todd Davis tells Proactive that it is optimistic it can now successfully apply to up-list its stock to trade on the OTCQB, with a long-term initiative to become Nasdaq listed, based on its current financials and adherence to compliance in the hemp sector.
What's more, it previously announced a 360% quarter-over-quarter improvement in its fourth-quarter 2021 revenue, as the company said it is establishing an upward trend that’s accelerating into fiscal 2022. Davis noted that the company remains driven and on track to achieving its objectives and long-term growth initiatives through continued expansion toward 20,000 Food/Drug/Mass (FDM) retail stores.
$AMMJ top of the list on the 2022 Grand Salami pick!!
https://investorshub.advfn.com/Sleekscapes-2022-Cannabis-Marijuana-Mania-Grand-Salami-Part-Ii-31243
$KOSK One Step Vending, Corp. is a holding company focused on the acquisition of market-changing and disruptive business models with an emphasis in the marketing and distributing produce as well as in the self-serve vending market. Currently One Step Vending, Corp. owns 51% of E-Roots Systems (Abbotsford), Ltd. markets and distributes the produce from vertically integrated farms purchased from E-Roots Systems, Inc., owns 10 vending machines designed to offer CBD and potential cannabis products.
Will The Taliban Allow Marijuana Operations For Real? German Cannabis Company Believes So.
They still grow and trade poppy: no wonder if they start Marijuana now. They don't care about Islamic Value as long as they're making money.
https://www.benzinga.com/markets/cannabis/21/12/24799045/will-the-taliban-allow-marijuana-operations-for-real-german-cannabis-company-believes-so
Endexx Corporation to open stores, cultivate marijuana, and distribute it in Jamaica! Seems like it's penetrating new international markets day by day; now waiting for its $EDXC PPS to penetrate and going nowhere but up!
$EDXC - EndexxCorp is ready to conform with any new FDA requirements as the new CBD Product Safety and Standardization Act is introduced.
Last week, a bipartisan group of four U.S. Representatives introduced the CBD Product Safety and Standardization Act, a bill to establish federal standards for CBD products. As a CBD wellness company with proprietary formulation, Endexx is already equipped to conform to any FDA requirements.
$EDXC - Endexx Corporation's CBD Unlimited and Blesswellco are leading the industry by predictable doses and the highest quality products. And these are going to work as catalysts for growth for the company.
$EDXC - @EndexxCorp Has Secured Purchase Orders with Major Retail Chain to Offer the Popular @Blesswellco Men’s Grooming Line which is increasing the PPS!
$STEV - Stevia Corp. Announces Non-Binding Purchase Offer for California-based Consumer Products Company
NEW YORK, NY / ACCESSWIRE / October 13, 2021 / Stevia Corp. (OTC PINK:STEV) ("Stevia Corp" or the "Company"), a healthcare company focused on the commercial development of products that support a healthy lifestyle announced today that it has submitted a non-binding purchase offer for a California-based consumer products company with multiple existing products, revenue and alleged profits. The company's products have received excellent online reviews from many consumers. Any final purchase agreements and a definitive closing is subject to extensive due diligence and there is no assurance that the seller will accept our current offer. The company was introduced to Stevia Corp. through a third-party relationship of the Chairman of Stevia Corp. If the current purchase offer is accepted by the selling company and the sale is closed, the current shareholders of Stevia Corp. will still own in excess of 90% of the public company. We are also reviewing other opportunities.
The current non-binding purchase offer is completely in line with the company's main goal of creating shareholder value. The seller's products seem to be well received by consumers based on many reviews of the company's products. Our due diligence will include a thorough review of financials, historic marketing budgets, repeat purchase data, manufacturing processes, competitive advantages and more.
Kenneth Maciora, Chairman and President of Stevia Corp. commented, "We are excited about the potential of this company and their products. To be clear, any closing is subject to our extensive due diligence and board approval and there is no assurance the sellers will accept our offer. We are not announcing the name of the company at this time for obvious reasons including the fact that we don't want to create a public announcement for competitive bids."
About Stevia Corp.
Stevia Corp. is a farm management company and healthcare company focused on developing highly nutritional, high value products through proprietary plant breeding, excellent agricultural methodologies and innovative post-harvest techniques. Stevia Corp was founded on the principal of implementing socially responsible, sustainable, quality agribusiness solutions to maximize the long-term efficient production of nutritional crops.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.
Contact:
Kenneth Maciora
President
Stevia Corp.
(917) 670-9541
steviapresident@gmail.com
SOURCE: Stevia Corp.
View source version on accesswire.com:
https://www.accesswire.com/667887/Stevia-Corp-Announces-Non-Binding-Purchase-Offer-for-California-based-Consumer-Products-Company
$STEV now listed under Cannabis Stocks
Stevia Corp. Issues Shareholder LetterPress Release | 09/30/2021 - https://www.otcmarkets.com/stock/STEV/news/Stevia-Corp-Issues-Shareholder-Letter?id=323031
Realhemp Website active in the last month - http://www.realhemp.com
DD Post: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166194893
HEMPFUSION CBD WELLNESS INC 2021 GUIDE
https://investorsscene.com/Company-Profile-HempFusion-Wellness-Inc/
NetworkNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Collaboration with the University of Milan for ‘Precedent-Setting Experiment’
RYAH Group (CSE: RYAH) today announced its entry into a strategic partnership with the University of Milan, a leading education and research institution, to develop and formalize universal milliliter (“ml”) to milligram (“mg”) conversion standards in dry herb cannabis inhalation therapies for its RYAH Smart Dry Herb Inhalers.
According to the update, the RYAH Smart Dry Herb Inhaler is an IoT-powered dry herb inhaler with an integrated volumetric airflow sensor that gives consumers the ability to track and control exactly how much they inhale.
“ Our collaboration with the University of Milan is expected to afford us an incredible opportunity to, among other things, rigorously map out how cannabis strains behave throughout a full heat-not-burn temperature spectrum at incremental volumes inhaled,” said Jordan Medley, head of product operations at RYAH. “This is a precedent-setting experiment that is expected to generate the data needed to facilitate an accurate milligram dosing experience with dry herb.”
Giving the quickly growing acceptance of MMJ in North America and globally, the governments (federal/national level) will implement a harmonized and common standard. Within this fact, I think RYAH Group is well-positioned.
The AI and IoT sector is becoming the main way, to compare and measure facts. With the set of products RYAH Group has in the market and developing new ones, I would say this company is something to consider for MMJ fans.
RYAH Group, Publishes Medical Cannabis Report On Use for Pain
RYAH Group, Inc Publishes Report on Medical Cannabis Use for Pain
TORONTO, June 10, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- RYAH Group, Inc. (CSE:RYAH) (“RYAH” or the “Company”) is pleased to announce that its wholly owned subsidiary, RYAH Medtech Inc. ("RYAH Medtech", has published a data report on use of medical cannabis among patients with pain conditions.
The data report features insights into the use of cannabis to treat pain conditions by patients within the RYAH Data ecosystem and whether cannabis may be one of the alternative treatment solutions to reduce opioid use-related problems associated with existing treatment options. The publication is based on user feedback provided by more than 40,000 patients that have reported to the RYAH Data ecosystem.
The report provides a breakdown based on patient gender, main conditions related to pain management and corresponding strain types and reveals that pain is one of the top three conditions for medical cannabis treatment within the RYAH Data ecosystem and also seems to be one of the most interesting symptoms for researchers. As of the date hereof, one of the world’s largest clinical trials in cannabis is focused specifically on pain management, and further to RYAH's recent press release, the RYAH Smart Dry-Herb Inhaler has been selected as the device for such study (with RYAH Medtech recently having completed its initial shipment of RYAH Smart Dry Herb Inhalers and RYAH Cartridges to the U.K. clinic conducting the study).
“The RYAH data report on cannabis use for pain management comes at a turning point as studies on alternatives to opioids in treatment and potential efficacy of chronic pain start to accelerate. The opioid crisis, which began with initially good intentions to more effectively treat pain, created a flood of opioids being prescribed, up from an estimated 70 million prescriptions in the 1990s to more than 255 million by 2012. RYAH is committed to providing the tools needed to effectively monitor and measure dosing in plant-based medicine treatments and to providing data analytics in order for the industry to make more informed decisions around alternative treatments to opioids."
Gregory Wagner, CEO of RYAH
View the Report
Learn more
About RYAH Group, Inc.
RYAH Group, Inc. (“RYAH”) is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies and licensed processors (LPs) to monitor and manage formulation effects on patients and demographics. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle.
Delta 8 Cartridges Near Meadow Land
While looking for Delta-8 CBD THC and Delta 8 THC products near meadow land, I came upon two more Delta products. One Delta product was a joint called Grasshopper from Delta, as well as another called the Grasshopper 2. Both joints looked identical to each other and were available for sale. The Grasshopper looked almost identical to the Delta 8 Weed but was shorter and lacked the sideburns on the Grasshopper.
While looking in an assortment of local pot shops, I came across the Delta-8 THC and Delta-8 CBD Weed. A few stores near me have both products. I went with Grasshopper for the moment, while searching for CBD THC and Grasshopper for another time. I will write that test later, but right now I am reviewing Delta-8 THC and CBD weed.
My search for Delta-8 THC Weed continued near meadow land. I found two more Delta-8 Weed products. This time they were a joint called the Grasshopper 2 and a pen. The Grasshopper 2 looked identical to the Grasshopper, except that it did not come with a side burner. It also had an herb labeled "Hemp," possibly indicating that it may contain marijuana.
I went back to the Delta-8 cartridges in my basket, thinking that perhaps they were just another product being sold by Area 52. After a quick search, I found a website where Delta-8 THC and CBD are listed. The website also contained directions for filling out a Delta-weed free trial, which I thought would be really neat since Delta-8 Weed is not yet legal in my state. Anyway, the directions instructed me to pop a cartridge into each of the two pens.
The Grasshopper and the pen showed two pictures. One showed a black and white photo of the Delta-8 THC, and the other displayed the item in its original color. After inserting the weed into the pen, the webpage told me to follow a series of steps, one of which instructed me to "roll the pin" (like a pencil). The paper was colored so it was easy to see where I was supposed to put the weed. After following the instructions, I pushed the button and the Grasshopper popped into action.
The delta 8 cart didn't take long to get me high. Soon I was high as can be! It's hard to explain how much better the experience was, except to say that I started thinking about all of the times I have craved cannabis, but could not smoke it because the laws were too strict. Maybe someday we can legally grow and consume hemp, but for now my choice is to stick with Delta-8 pens!
$OXIHF-.007 cents- launches CBD sales/hemp farming website - PioneerGreen Farm.com
They are growing in Florida- Hemp farm pictures and videos
$MINE's 12 acre grow facility is located in Jamaica, and have also partnered with Lazarus Holistic Ltd. on a licensed cannabis facility in Jamaica. In early 2021 they intend to acquire land in two other legal markets, Oregon and Vermont. https://www.minercoinc.com/real-estate
$SNDL - Looking to buy back in at $1.50
$SNDL Now $4+ Congrats to all who got in when I first posted here
I played that one earlier for a triple bagger. Did not stick around. I just didn't trust the stock. But I have been proved wrong.
Profitable?
Cannabis Investment Club
https://investorshub.advfn.com/Cannabis-Investment-Club-33161/
JohnCM Investment Corner
https://investorshub.advfn.com/JohnCM-Investment-Corner-37729/
Here is my Stock Investment Newsletter.
https://docs.google.com/document/d/1e37ezUfDkZ7TSiEwRStGnoYqGSzWXskkMfcpMg-9KVo/edit?usp=sharing
JohnCM
Did You SEE LXRP YESTERDAY!!!
From penny stock to Nasdaq and growing.
Lexaria Bioscience Corp - the stock of the year 2021?
Cannabix Technologies Granted U.S. Patent - Cannabis Drug Detection Device
For immediate release. Vancouver, British Columbia, January 12, 2021: Cannabix Technologies Inc.(CSE: BLO, OTC PINK: BLOZF) (the “Company”) developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, announces that the United States Patent and Trademark Office (USPTO) has granted patent No. 14/689434 entitled, “Cannabis Drug Detection Device” to the Company.
Increased CBD orders and news about who the big name customer is, Lexaria may become a true winner and a money maker as well.
What kind of customer are they talking about?
Lexaria Bioscience has broadened its COVID-19 drug exploration program, and they believe its DehydraTech has the potential to significantly increase bio-availability, safety, and efficacy for many oral antiviral medications. This development is expected to make oral antiviral drugs work more effectively for better therapeutic outcomes and at lower doses than are otherwise necessary in order to minimize unwanted side effects. In turn, this may also make the oral route of administration a viable alternative to injection. One such drug of note is the antiviral remdesivir. This is a game changing and disruptive technological development.
Yesterday, LXRP did a one for 30 reverse split in order to qualify for the NASDAQ, and is anticipated to list with a new symbol LEXX today. Opening price is expected to be $7.50 per share once fully approved and listed.
I checked this morning and as of 5:00am central it comes up as LXRPD on OTC, but on TD Ameritrade it comes up as LEXX and is listed as NASDAQ. In conjunction with this up-listing, the company intends to raise 1.8 million dollars.
Listing on a major U.S. exchange should not be overlooked because NASDAQ is backed by serious money, and media is not so shy about suggesting major exchange listed stocks as opposed to OTC listed companies. Chris Bunka (CEO of Lexaria) has stated numerous times he needed this listing to garner the attention of the big pharmaceutical companies, big tobacco, and big beverage companies he intends to partner with. Potentially, this up-listing could be just the beginning, and no one knows where it might end up.
If fully listed on NASDAQ today, Lexaria has accomplished a major feat that many OTC companies only talk about or merely dream of doing. Today, a new reality may dawn.
FacebookTwitterLinkedInCopy LinkMore
(0) (0)
Bought 0.15 sold 0.40
Wouldn't touch it now.
SNDL Stock: Sundial Growers Represents a Huge Opportunity
December 18, 2020 by Joshua Rodriguez
Link:
https://cnafinance.com/sndl-stock-sundial-growers-represents-a-huge-opportunity/
Sundial Growers Inc (NASDAQ: SNDL) has been a hot topic of conversation as of late, and for good reason. After a recent dramatic run for the top, profit takers have stepped in, leading to declines. At the same time, the overall cannabis sector is having a great time thanks to coming regulatory changes.
Now the question is, “Will the stock head back for the top?” In my opinion, the answer is a resounding, “Yes!”
Skip to What You Want to Read
Sundial to Benefit Greatly From Regulatory Changes
The Company Is a Perfect Acquisition Target
What Analysts Think About SNDL Stock
Risks to Consider Before Buying SNDL Stock
Final Thoughts
Sundial Growers to Benefit Greatly From Regulatory Changes
While Sundial Growers hasn’t quite shared in the run, the cannabis sector has been seeing some pretty strong gains, and for good reason. At the end of the day, regulatory changes will likely open the door to a vast global market over the next few years.
At the moment, we’re seeing quite a bit on the topic of cannabis legalization in the UK and across Europe. Of course, legalization in these regions would open massive markets for any cannabis grower, including SNDL.
However, the bigger story is the fact that cannabis may soon become legal in the United States.
Recently, the house of representatives voted to remove cannabis from the list of controlled substances in the United States. At the moment, the move is highly symbolic since changes can’t be made without approval from the Senate, but it’s a major step in the right direction for cannabis companies and consumers.
Ultimately, the next step is for the Senate to vote on the measure. If it passes, and many believe it will, adults will soon be able to legally buy cannabis in the United States, the world’s largest economy.
While other cannabis stocks have seen a pretty robust reaction to the news, SNDL has lagged behind, suggesting that there’s a major opportunity ahead.
The Company Is a Perfect Acquisition Target
Beyond the potential for gains that could come as regulatory changes make cannabis a legal drug around the world, there’s quite a bit of opportunity in the fact that SNDL represents a perfect acquisition target.
As its name would suggest, Sundial Growers is a cannabis growing operation. However, the company has recently broken into the cannabis vape market, a growing market that many believe will result in higher demand than dry flowers.
At the same time, the edibles market is a massive one, and yet another market that Sundial is currently working on breaking into.
With the regulatory changes that are likely ahead, and Sundial Growers breaking into key markets like the edibles and vape markets, it only makes sense that the company would be in demand for a larger player looking to consolidate the market.
Furthermore, SNDL stock has had a pretty rough time in the market over the past year. While that’s a painful reality for investors, it also means that a suitor would receive a discount in a potential acquisition.
What Analysts Think About SNDL Stock
One of the factors that’s likely holding SNDL stock down in a time when cannabis stocks are flying is analyst opinions. Unfortunately, analysts don’t see SNDL as an opportunity.
At the moment, there are two analysts weighing in on the stock, one with a Hold and one with a Sell rating. There aren’t any analysts currently rating the stock a buy. Moreover, the high price target on the stock is $0.30 with the low being $0.20, for a consensus estimate of $0.25.
While that’s a grim outlook from analysts, SNDL has improved over the past few months, and none of these ratings are anything new or updated. As a result, I believe that analyst views on the stock are outdated and that SNDL does indeed offer up an opportunity, especially considering its standing as a potential takeover target.
Risks to Consider Before Buying SNDL Stock
Anytime you make an investment, you’re accepting the risks that come along with that investment. Sundial Growers is no different. In fact, the risks associated with the stock are quite significant. Nonetheless, you can’t expect significant gains without being willing to accept significant risks. Before you buy SNDL stock, consider the following:
Regulatory Risks. Cannabis is a highly regulated industry, and for the most part, the substance is illegal around the world. Although regulatory changes are taking place, this process can be slow. Moreover, if cannabis doesn’t become legal in major markets outside of Canada relatively soon, the sector could feel significant pain.
The Company Isn’t Making Any Money. Like many in the cannabis sector, Sundial Growers doesn’t make any money. Sure, it drives revenue through the sale of its product, but it also has far more cash flowing out of the business than the amount coming in. If the company can’t get to profitability soon, it may look toward capital markets as a way to raise funds, which would dilute value for existing shareholders.
Penny Stock Risks. By nature, penny stocks are a highly speculative play, riddled with risk. First and foremost, high volatility opens the door for potentially significant losses. Moreover, companies at this stage in the game have quite a bit to prove, with little to show by way of market penetration. Essentially, SNDL, like most other penny stocks, has a long way to go to become uber successful.
A Speculative Investment. My investment thesis is based on Sundial Growers having what it takes to get out of hard times, tap into multiple markets, and potentially be acquired. All of this is speculative and with heavy speculation comes heavy risk.
Final Thoughts
Ultimately, I didn’t write the risk section above to scare you off. Nonetheless, it’s important to consider the risks before making any investment.
Nonetheless, I see Sundial Growers as a major opportunity. As regulatory changes continue to go in the right direction, the opportunity for revenue expansion and a push to profitability grows. So too does the potential for a complete takeover of the company by one of the major players in the space.
$RSCF .88 Reflect Scientific Introduces Liquid Nitrogen Cooling Technology to Booming Cannabis Market
The company has released the Cryometrix L-80 liquid chiller, a new product for the cannabis extraction market.
Hemp Grower Link:
https://www.hempgrower.com/article/reflect-scientific-introduces-liquid-nitrogen-cooling-technology-to-cannabis-market/
Lexaria Biotech Uplisting Closer Now!
$LXRP --- During 2020 we repeatedly told our shareholders that we thought we needed to move to a senior US securities exchange. We trade on the Canadian Securities Exchange and we are also quoted on the OTCQX – the highest tier of the OTC markets.
A lot of people don’t realize the OTC is not actually a stock exchange. As such, the vast majority – possibly over 90% - of all the investible money in the USA is disallowed from investing in OTC securities. This includes most institutional money, mutual funds, family offices, ETF’s and more. Even the very popular US trading platform RobinHood only allows its customers to trade securities listed on the NYSE and Nasdaq. The bottom line is simple: in order for Lexaria to be accessible to the majority of US capital, we need a senior US securities exchange listing.
We received overwhelming shareholder support to do so at our last AGM, and our up-list program is, we think, getting close to being complete. Final timing is out of our hands but we certainly expect and hope it to take place during the first quarter of 2021. Our investment banking partner is ready to proceed and the necessary filings are being made with the SEC and others.
Our US exchange up-listing is the single most exciting development to happen to Lexaria and we hope that the ability of a vastly larger pool of capital to invest into Lexaria will assist in our pursuit of increasing shareholder value.
UGRO - Urban-Gro, Inc
OTCQX hidden gem
Currently trading at $1
Float
6,815,169
urban-gro, Inc. is a leading engineering design services company that integrates complex equipment systems into high-performance indoor cultivation facilities for the global commercial horticulture market. Our custom-tailored, plant-centric approach to design, procurement, and integration provides a single point of accountability across all aspects of indoor growing operations. We also help our customers achieve operational efficiency and economic advantages through a full spectrum of professional services focused on facility optimization, and integrated pest management programs that promote environmental health. In every engagement, our unwavering focus is on solutions that ensure success.
https://urban-gro.com/
Latest Filing
https://www.otcmarkets.com/filing/html?id=14475701&guid=0UteUn10eYI8Pyh
Followers
|
535
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
39884
|
Created
|
01/05/14
|
Type
|
Free
|
Moderator DollarsOnPennies | |||
Assistants DollarsOnPennies |
Posts Today
|
0
|
Posts (Total)
|
39884
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |